Task: Answer the multiple-choice question.
Question: Which drug exhibits a 17.333% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) CSCCC(N=C(NS(=O)(=O)c1ccc(Br)cc1)c1ccccc1)C(=O)O
b.) Cc1ccnc(NS(=O)(=O)c2cccc([N+](=O)[O-])c2)c1
Answer: a. CSCCC(N=C(NS(=O)(=O)c1ccc(Br)cc1)c1ccccc1)C(=O)O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CSCCC(N=C(NS(=O)(=O)c1ccc(Br)cc1)c1ccccc1)C(=O)O
CSCCC(N=C(NS(=O)(=O)c1ccc(Br)cc1)c1ccccc1)C(=O)O
2-[[[(4-bromophenyl)sulfonylamino]-phenylmethylidene]amino]-4-methylsulfanylbutanoic acid